-
3.1
Collect the appropriate information required for cancer-related pharmacotherapy assessment
Essential
-
3.2
Ensure the cancer-related pharmacotherapy plan is indicated and appropriate
Essential
-
3.3
Ensure the drug, dose, formulation, and scheduling is expected to be effective to meet the cancer-related health
Essential
-
3.4
Ensure the cancer-related drug, dose, formulation, and scheduling is expected to be safe
Essential
-
3.5
Evaluate if the cancer-related drug is reasonably accessible
Essential
-
3.6
Optimize patient adherence to cancer-related pharmacotherapy
Essential
-
3.7
Ensure follow-up and ongoing pharmacist assessment as appropriate
Essential
-
3.8
Ensure safety standards are maintained in anticancer pharmacotherapy preparation, distribution, dispensing
Essential